Immunoprotective efficacy of 3 Klebsiella pneumoniae type I fimbriae proteins in a murine model.
Vet Microbiol
; 297: 110197, 2024 Oct.
Article
in En
| MEDLINE
| ID: mdl-39126781
ABSTRACT
Klebsiella pneumoniae is a primary cause of clinical mastitis in dairy cows, with prevention being crucial, as treatments often fail due to antimicrobial resistance. Recent studies identified type I fimbrial antigens of K. pneumoniae as promising vaccine candidates, but there are limited research data. In this study, 3 fimbriae genes (fimA, fimC and fimG) were cloned and recombinantly expressed in Escherichia coli and their protective efficacy against K. pneumoniae evaluated in a mouse model. All 3 recombinant fimbriae proteins elicited strong humoral immune responses in mice, significantly increasing IgG, IgG1 and IgG2a. Notably, using a model of mice challenged with an intraperitoneal injection of bacteria, FimG significantly reduced bacterial loads in the spleen and lung, whereas FimA and FimC had limited protection for these organs. Either active or passive immunization with FimG produced substantial protective effects in mice challenged with K. pneumoniae LD100; in contrast, the mortality rate in the FimA-immunized group was similar to that of the control group, whereas FimC had weak protection. We concluded that the FimG recombinant protein vaccine had a favorable protective effect, with potential for immunization against K. pneumoniae mastitis.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Klebsiella Infections
/
Bacterial Vaccines
/
Fimbriae Proteins
/
Disease Models, Animal
/
Klebsiella pneumoniae
/
Mice, Inbred BALB C
/
Antibodies, Bacterial
Limits:
Animals
Language:
En
Journal:
Vet Microbiol
Year:
2024
Document type:
Article
Country of publication: